AB1371 FIVE-YEAR EXPERIENCE IN A MULTIDISCIPLINARY PNEUMOLOGY-RHEUMATOLOGY CONSULTATION WITH SYSTEMIC AUTOIMMUNE DISEASE: CLINICAL-RADIOLOGICAL CHARACTERIZATION OF PULMONARY INVOLVEMENT AND PATIENT PERCEPTIVE QUALITY ASSESSMENT
Authors: C. M. Gomez-Gonzalez, P. Cardoso-Peñafiel, L. Cebrián-Méndez, M. F. Pino-Zambrano, A. I. Higes-Díaz, D. Martos-Ruiz, C. Araque-Molina, L. Lojo-Oliveira, E. Calvo-Aranda, C. Marín-Huertas, M. Sanz-Jardón, A. Pareja-Martinez, T. Navio-Marco, B. López-Muñiz
Journal: Annals of the Rheumatic Diseases (2024)

<h3>Background:</h3> Among the pulmonary complications of Systemic Autoimmune Diseases (SAD), interstitial lung disease (ILD) stands out, which can appear at any time during the progression of the disease. Its clinical course is usually insidious, being the most frequent symptoms dry cough and dyspnea, initially on exertion. <h3>Objectives:</h3> To describe the clinical and radiological characteristics, and degree of satisfaction of patients with diagnosis or suspicion of SAD and pulmonary involvement evaluated in a multidisciplinary consultation of Pneumology-Rheumatology. <h3>Methods:</h3> Retrospective observational study of a cohort of patients with SADs followed in multidisciplinary consultation of Pneumology-Rheumatology from October 2017 to September 2022. A perceived quality survey was conducted from June to September 2022, including demographic and satisfaction data regarding assistance. <h3>Results:</h3> A total of 185 patients were included, (67%) women; with an average age of 62 years. The table shows the prevalence of the different SADs evaluated and the different pulmonary radiological findings. As for immunosuppressants received: Methotrexate 4 (2.8%), mycophenolate 35 (24.1%), rituximab 21 (14.5%), abatacept 4 (2.8%), azathioprine 5 (3.4%), tocilizumab 2 (1.3%), tofacitinib 1 (0.7%) and cyclophosphamide 6 (4.1%). Antifibrotic drugs (pirfenidone and nintedanib) were used in 2 and 7 patients, respectively. 40 patients (21.6%) did not receive treatment, with clinical and radiologic follow-up in successive in follow up. Out of the patients evaluated, 26 (14.1%) died: 7 from SARS-CoV-2 infection, 5 from progression of ILD, 2 from exacerbation of ILD, 4 from cancer (3 lung, 1 colon), 5 from cardiovascular disease, and 3 from unknown causes. In terms of perceived quality, 53 patients completed the survey. Thirty-seven (69.8%) patients were very satisfied with the multidisciplinary consultation, 14 were satisfied (26.4%) and 2 did not answer. And respect to the time spent on duration of consultation, 56.6% of patients stated that they were very satisfied, 30.5% were satisfied and the 13% did not answer. 71.7% responded that they totally or partially agreed to be seen jointly by both specialists, 26.4% were indifferent and 1 disagreed. <b>Table 1.</b> <h3>Conclusion:</h3> In the sample studied in our multidisciplinary practice, there is a significant number of patients with SADs and pulmonary affectation, with a high prevalence of ILD, the most frequent pattern being NSIP, as described in the related literature. Most patients are very satisfied with the combined care model, making it an important management tool for better treatment and follow-up. <h3>REFERENCES:</h3> <b>NIL.</b> <h3>Acknowledgements:</h3> <b>NIL.</b> <h3>Disclosure of Interests:</h3> <b>None declared.</b>